Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Universal Technical Institute
UTI
$1.39B
| $4.52M | 0.01% |
1,265,700
+113,100
| +10% | +$408K |
|
|
NRE
1777
DELISTED
NorthStar Realty Europe Corp.
NRE
| $4.52M | 0.01% |
356,300
+342,100
| +2,409% | +$4.13M |
|
1778
Shore Bancshares
SHBI
$800M
| $4.51M | 0.01% |
273,900
-21,200
| -7% | -$352K |
|
1779
Stryker
SYK
$130B
| $4.48M | 0.01% |
32,300
+25,100
| +349% | +$3.44M |
|
|
INTX
1780
DELISTED
Intersections, Inc.
INTX
| $4.48M | 0.01% |
953,301
+36,301
| +4% | +$172K |
|
|
ABCD
1781
DELISTED
Cambium Learning Group, Inc.
ABCD
| $4.48M | 0.01% |
883,100
+52,800
| +6% | +$263K |
|
|
ARII
1782
DELISTED
American Railcar Industries, Inc.
ARII
| $4.47M | 0.01% |
+116,600
| New | +$4.5M |
|
1783
Astronics
ATRO
$4.61B
| $4.46M | 0.01% |
201,894
+98,118
| +95% | +$2.2M |
|
|
HPP
1784
Hudson Pacific Properties
HPP
$754M
| $4.46M | 0.01% |
18,629
-40,828
| -69% | -$9.8M |
|
1785
AstraZeneca
AZN
$243B
| $4.46M | 0.01% |
+65,350
| New | +$4.27M |
|
|
CCUR
1786
DELISTED
CCUR Holdings, Inc. Common Stock
CCUR
| $4.45M | 0.01% |
669,119
| – | – |
|
|
CYS
1787
DELISTED
CYS Investments Inc.
CYS
| $4.45M | 0.01% |
+528,600
| New | +$4.44M |
|
|
BHBK
1788
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $4.44M | 0.01% |
248,180
-89,320
| -26% | -$1.62M |
|
|
SF
1789
Stifel
SF
$12.9B
| $4.44M | 0.01% |
+217,298
| New | +$4.46M |
|
1790
First Bancorp
FNLC
$402M
| $4.44M | 0.01% |
164,000
-16,823
| -9% | -$446K |
|
1791
Silicon Motion
SIMO
$9.12B
| $4.44M | 0.01% |
91,979
-318,800
| -78% | -$15.8M |
|
1792
Bankwell Financial Group
BWFG
$543M
| $4.42M | 0.01% |
141,547
-2,749
| -2% | -$92.5K |
|
1793
UNIFI
UFI
$120M
| $4.41M | 0.01% |
143,300
-13,200
| -8% | -$373K |
|
|
SNBC
1794
DELISTED
Sun Bancorp Inc
SNBC
| $4.41M | 0.01% |
178,879
-6,200
| -3% | -$155K |
|
|
DST
1795
DELISTED
DST Systems Inc.
DST
| $4.38M | 0.01% |
+70,900
| New | +$4.32M |
|
|
CSLT
1796
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $4.37M | 0.01% |
1,052,500
+129,700
| +14% | +$506K |
|
|
FLY
1797
DELISTED
Fly Leasing Limited
FLY
| $4.34M | 0.01% |
322,900
+33,517
| +12% | +$435K |
|
1798
Advanced Drainage Systems
WMS
$11.4B
| $4.34M | 0.01% |
216,000
+76,263
| +55% | +$1.64M |
|
1799
Brookdale Senior Living
BKD
$3.02B
| $4.33M | 0.01% |
+294,004
| New | +$4.06M |
|
1800
TriNet
TNET
$3.16B
| $4.33M | 0.01% |
+132,100
| New | +$4.03M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.